mesalamine has been researched along with Arteriosclerosis, Coronary in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coronary artery ectasia (CAE) can be ascribed, in the majority of cases, to coronary atherosclerosis." | 1.48 | Coronary artery ectasia in Crohn's disease. ( Katritsis, G; Korovesis, T; Koudounis, P; Zografos, T, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korovesis, T | 1 |
| Katritsis, G | 1 |
| Koudounis, P | 1 |
| Zografos, T | 1 |
1 other study available for mesalamine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Coronary artery ectasia in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Coronary Angiography; Coronary Artery Disease; Crohn Diseas | 2018 |